Mid-Year FY19 Pharmaceutical Outlook: Outlook Stable Despite Intensifying Profitability Headwinds

New Delhi, September 06, 2018: India Ratings and Research (Ind-Ra) has maintained a stable outlook for the pharmaceutical sector for the…

Following a good second quarter, LANXESS specifies its earnings forecast for 2018

Full year 2018: Increase of EBITDA pre exceptionals now expected at the upper end of the guidance of five to…

Narayana Hrudayalaya Limited Q1 FY19 Consolidated operating income at Rs 6,523 mn (y-o-y of 25.2%) with EBITDA of Rs 504 mn

Bengaluru, August 06, 2018: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the…

• Archives

Funds advised by Apax Partners receive binding offer for Azelis

New Delhi, June 24, 2018: Azelis, a leading global specialty chemicals and food ingredients distributor, today announced that Funds advised…

• Archives

Torrent Pharma readies €2 billion binding offer for Sanofi’s European unit

Mumbai, March 08, 2018: Torrent Pharmaceuticals Ltd is readying a €2 billion (Rs16,000 crore) bid for Zentiva N.V., the generic drugs…

Apollo Hospitals announces Q3FY18 results

New Delhi, February 15, 2018: Q3FY18 Standalone Revenues grew 13% to Rs. 18,961 million compared to Rs. 16,806 million in Q3FY17,…

Granules India’s Revenue from operation increases by 14% to INR 411 Cr.

Mumbai, February 09, 2018: Granules India Ltd., a growing pharmaceutical manufacturing company, announced today financial results for its third quarter…

HealthCare Global Enterprises Ltd. reports Q3-FY18 results

Revenue for Q3 FY18 of INR 2,063 Million, a growth of 17% (y-o-y) and for 9M FY18 of INR 6,084…